Japan vs Slovenia: Cause of death, by non-communicable diseases, ages 15-59, male
Japan
72.4%
in 2021
Slovenia
73.4%
in 2021
Japan rank
21st
Slovenia rank
18th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Japan
- Slovenia
How they compare
Slovenia currently reports 73.4% against 72.4% in Japan, a difference of 1.0%.
Across all 6 years both countries report, Slovenia has been ahead every year.
Japan ranks 21st and Slovenia ranks 18th of 185 countries.
Slovenia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Japan | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 67.0% | 70.9% | 3.9% | Slovenia |
| 2010s | 70.4% | 75.5% | 5.1% | Slovenia |
| 2020s | 73.0% | 73.6% | 0.6% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Japan or Slovenia?
- Slovenia, at 73.4% against 72.4% in Japan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Japan and Slovenia?
- 1.0%, with Slovenia ahead.
- How many years of comparable data are there for Japan and Slovenia?
- 6 years are reported by both, from 2000 to 2021.
- How do Japan and Slovenia rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Japan ranks 21st and Slovenia ranks 18th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.